持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/11/18 | 日証協 | 117,897株 | -5.84% | 35,309株 | -25.03% | 76,199株 | -10.35% | 2,942株 | -65.79% |
2016/11/11 | 日証協 | 125,212株 | -11.54% | 47,095株 | -6.04% | 84,999株 | -5.97% | 8,600株 | +11.28% |
2016/11/04 | 日証協 | 141,540株 | +0.12% | 50,121株 | +0.05% | 90,399株 | -0.25% | 7,728株 | -17.1% |
2016/10/28 | 日証協 | 141,366株 | +1.24% | 50,098株 | +227.65% | 90,628株 | +1.28% | 9,322株 | -44.41% |
2016/10/21 | 日証協 | 139,632株 | +14.21% | 15,290株 | -62.06% | 89,483株 | +4.1% | 16,768株 | +61.92% |
2016/10/14 | 日証協 | 122,255株 | +10.42% | 40,300株 | +8.21% | 85,959株 | -3.85% | 10,356株 | -14.12% |
2016/10/07 | 日証協 | 110,718株 | +22.63% | 37,244株 | +0.76% | 89,399株 | -1.06% | 12,059株 | -69.51% |
2016/09/30 | 日証協 | 90,284株 | -21.01% | 36,964株 | +341.47% | 90,353株 | -4.78% | 39,546株 | +144.72% |
2016/09/23 | 日証協 | 114,298株 | +5.42% | 8,373株 | -77.38% | 94,892株 | -1.04% | 16,160株 | -18.96% |
2016/09/16 | 日証協 | 108,425株 | -9.6% | 37,019株 | -19.15% | 95,892株 | -17.45% | 19,940株 | -31.8% |
2016/09/09 | 日証協 | 119,939株 | -3.17% | 45,787株 | -29.08% | 116,161株 | -1.4% | 29,239株 | -30.73% |
2016/09/02 | 日証協 | 123,868株 | -1.82% | 64,566株 | +40.39% | 117,811株 | -7.1% | 42,212株 | +122.15% |
2016/08/26 | 日証協 | 126,168株 | +1.61% | 45,989株 | +45.11% | 126,810株 | -0.69% | 19,002株 | -12.46% |
2016/08/19 | 日証協 | 124,170株 | +5.07% | 31,693株 | +26.27% | 127,691株 | +1.75% | 21,706株 | -26.76% |
2016/08/12 | 日証協 | 118,181株 | -14.03% | 25,100株 | -45.21% | 125,491株 | +6.04% | 29,637株 | -33.01% |
2016/08/05 | 日証協 | 137,468株 | +8.36% | 45,812株 | -4.89% | 118,341株 | +4.59% | 44,243株 | +171.43% |
2016/07/29 | 日証協 | 126,867株 | -3.24% | 48,165株 | -4.96% | 113,145株 | -1.63% | 16,300株 | +32.06% |
2016/07/22 | 日証協 | 131,112株 | +16.11% | 50,676株 | +26.08% | 115,019株 | -1.22% | 12,343株 | -21.66% |
2016/07/15 | 日証協 | 112,919株 | -12.63% | 40,192株 | +41.18% | 116,443株 | -6.35% | 15,756株 | +4.23% |
※株式分割は考慮していませんのでご注意ください。
Page Top